Estimates of absolute cause-specific risk in cohort studies.
about
Long-term outcome of otherwise healthy individuals with incidentally discovered borderline thrombocytopeniaSilicosis among gold miners: exposure - response analyses and risk assessmentLong-term follow-up after uveal melanoma charged particle therapy.Population-based absolute risk estimation with survey dataNon-parametric estimation of bivariate failure time associations in the presence of a competing riskProportional hazards model for competing risks data with missing cause of failureCumulative incidence for wait-list death in relation to length of queue for coronary-artery bypass grafting: a cohort study.Change in disability after hospitalization or restricted activity in older personsEstimation of the standardized risk difference and ratio in a competing risks framework: application to injection drug use and progression to AIDS after initiation of antiretroviral therapyRisk.Model for individualized prediction of breast cancer risk after a benign breast biopsy.An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study.Risk factors and precipitants of long-term disability in community mobility: a cohort study of older persons.Crude incidence in two-phase designs in the presence of competing risks.The use and interpretation of competing risks regression modelsPredicting Adverse Health Outcomes in Long-Term Survivors of a Childhood Cancer.Absolute risk regression for competing risks: interpretation, link functions, and predictionComparing center-specific cumulative incidence functions.Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer.Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort studyIndividualized Absolute Risk Calculations for Persons with Multiple Chronic Conditions: Embracing Heterogeneity, Causality, and Competing Events.Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.A parametric method for cumulative incidence modeling with a new four-parameter log-logistic distribution.Analysing clinical studies: principles, practice and pitfalls of Kaplan-Meier plots.Adverse birth outcomes in United Republic of Tanzania--impact and prevention of maternal risk factors.Assessment of the accuracy of the Gail model in women with atypical hyperplasia.Choice and interpretation of statistical tests used when competing risks are present.Targeting of low-dose CT screening according to the risk of lung-cancer death.Epidemiology of incident heart failure in a contemporary elderly cohort: the health, aging, and body composition study.Developing points-based risk-scoring systems in the presence of competing risks.Two-stage sampling designs for external validation of personal risk models.Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro.Standard and reduced doses of dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study.Smooth semi-nonparametric (SNP) estimation of the cumulative incidence function.Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study.Direct likelihood inference and sensitivity analysis for competing risks regression with missing causes of failure.Inference for cumulative incidence quantiles via parametric and nonparametric approaches.Omnibus tests for comparison of competing risks with adjustment for covariate effects.Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study.Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction.
P2860
Q25257298-7D5D45E5-F1B9-47C1-94F4-BAF13619E209Q26341582-92B03759-7272-4FD2-88ED-DDD16F25F600Q30502671-68B86B0B-7F14-4A20-81EC-4765438DC69DQ30628233-B41D3E74-A481-4F5B-9EA5-26FCE04DB2B6Q33738055-E7D78A9D-7DF8-4F70-8527-8A0D680C5C6BQ34216679-3281072E-AA55-4C0A-ADB0-FBDCD78AA8DAQ35024594-687397F3-6125-4592-A3A2-1682106AA48BQ35073128-2FF2A156-6FB7-42D1-B2E8-052366BB5607Q35076584-C50F350A-3D8A-4D15-96C3-5E611F4D626DQ35076598-F1480E85-D974-474E-A6F7-DC4F48E07A2FQ35144259-F17B1744-BF91-4CE2-9EB0-58CF9C7D0DF0Q35274864-9052E313-BC20-4109-8855-F32774D35E6FQ35754849-E184E9C9-9BE5-42A6-8625-D99DC23FFBE8Q35891186-BD305A1E-8FB2-461C-BEAD-0273E9BFC73BQ35894830-AAB98263-9B14-4DFE-B36B-1CB979332BD7Q35906444-3701CA67-0674-4E57-BF9B-8FA5E2BD5818Q35990465-64B65026-939A-459D-81BD-03F9FD7A6510Q36075072-C319118F-4373-4235-A4F8-48C79CBCA3F6Q36490042-D899E1D9-4CF8-487C-9E5E-7F5FAA50F5FFQ36649796-CAEE5032-9E4E-473A-99F8-A01482974465Q36787662-0B5D647A-B5F3-4A02-8411-385ABC8DA83FQ36984154-BF80F7BB-0AD1-42F1-8EB4-FF2D12972472Q37018187-98C1C68A-20BE-4C87-BEDD-9F2BDB69CD93Q37082878-47A42063-15EF-4173-A10C-A0C9EB17C62CQ37084492-46EC9756-92F6-4E18-8DF1-6F61AE946358Q37117079-5501B2FA-E039-4E2D-97B8-C2449B047DEEQ37124914-021FE035-2AAD-4C91-9875-241C4F8F9277Q37198867-9B3C7DEB-578E-461D-A88F-229DE50D61C7Q37374537-23C6D49B-BD11-4DD8-8BFB-D3FD83660A32Q37375552-26211098-E86C-4DE5-A7B9-71F838F0B924Q37676179-6EFC601A-E0BC-4A28-BB5D-67D7DA5D0202Q38496638-79BD5BEB-AF4D-411D-B5D8-2F5D2650C1FFQ38598302-D3B87A43-5C26-4586-A795-FAE24B574ACAQ38764409-283BC46B-BF46-477F-ABCE-D9C2C49B41A8Q39289650-4A201F98-B136-4464-BF77-FD6E2FBBDB28Q41243268-1CF806FF-952E-407B-9ADE-2CECB63F6C4DQ45378695-DAB34D74-5A70-4CEB-89FF-2036598319E3Q46199685-0AC2B343-A27E-42EB-BC3E-F76C41687A31Q47955282-48371EFD-4D20-4CDF-9A72-E9392308105FQ48200162-143981AE-BF2B-421A-950D-A22059FB92DB
P2860
Estimates of absolute cause-specific risk in cohort studies.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Estimates of absolute cause-specific risk in cohort studies.
@en
Estimates of absolute cause-specific risk in cohort studies.
@nl
type
label
Estimates of absolute cause-specific risk in cohort studies.
@en
Estimates of absolute cause-specific risk in cohort studies.
@nl
prefLabel
Estimates of absolute cause-specific risk in cohort studies.
@en
Estimates of absolute cause-specific risk in cohort studies.
@nl
P356
P1433
P1476
Estimates of absolute cause-specific risk in cohort studies.
@en
P2093
P304
P356
10.2307/2532098
P407
P577
1990-09-01T00:00:00Z